Parkinson's study watches symptoms without new drugs

NCT ID NCT05779475

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows 96 people with moderate Parkinson's disease for up to 24 months. Participants take their usual medications, and doctors may adjust them as needed. Researchers will track motor symptoms using standard rating scales to better understand how the disease progresses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Show contact details

Locations

Clinical Neuroscience

Cambridge, CB2 0PY, United Kingdom
Joe C.Wen & Fam CTR for Adv Care

Irvine, California, 92612, United States
Keio University Hospital

Shinjuku-ku, Tokyo, 160-8582, Japan
NY Presbyt Hosp-W Cornell Med

New York, New York, 10021, United States
NYU Langone Health

New York, New York, 10016, United States
Neurologimottagningen Lund

Lund, 222 42, Sweden
Region Skane Skanes Universitetssjukhus

Lund, 222 42, Sweden
University of Cambridge - Clinical Neuroscience

Cambridge, CB2 0PY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.